A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : wtKRAS / wild-type KRAS

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   wtKRAS  (>> Co-occurring Abbreviation)
Long Form:   wild-type KRAS
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study. CLM, LR, mKRAS, R1vasc
2019 Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients. CRC, mCRC, OR, OS
2019 The association of KRAS mutation with primary tumor location and survival in patients undergoing resection of colorectal cancers and synchronous liver metastases. DSS, m-KRAS, SEER
2019 The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases. OS
2017 Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1. CRC, EGFR, TTDs
2016 Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells. CRC, CTCs, ISET, mCRC, PFS
2015 Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. CRLM, HR, KRAS, mtKRAS, OS
2015 Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases. CRLM, mtKRAS, OS
2015 Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view. BEV, mCRC, OS, PFS
10  2013 Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study. ORR, OS, P-XELOX
11  2011 Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis. mCRC, OR, OS, TTP, wt-BRAF
12  2010 KRAS mutations in Slovene patients with colorectal cancer: frequency, distribution and correlation with the response to treatment. ---